Exercise, vascular stiffness, and tissue transglutaminase.

Seeking a blood pressure-independent measure of vascular properties. Hypertens Res (2015) 0.90

Long term gluten consumption in adults without celiac disease and risk of coronary heart disease: prospective cohort study. BMJ (2017) 0.85

Age-associated pro-inflammatory remodeling and functional phenotype in the heart and large arteries. J Mol Cell Cardiol (2015) 0.81

Transglutaminase 2 promotes PDGF-mediated activation of PDGFR/Akt1 and β-catenin signaling in vascular smooth muscle cells and supports neointima formation. J Vasc Res (2015) 0.79

The Effects of Hemodynamic Changes on Pulse Wave Velocity in Cardiothoracic Surgical Patients. Biomed Res Int (2016) 0.77

The Pressure of Aging. Med Clin North Am (2017) 0.76

Mechanical heterogeneities in the subendothelial matrix develop with age and decrease with exercise. J Biomech (2016) 0.75

How old are your arteries? Exercise-mediated protection from age-associated vascular stiffness. J Am Heart Assoc (2014) 0.75

miR-181b regulates vascular stiffness age dependently in part by regulating TGF-β signaling. PLoS One (2017) 0.75

Tissue Transglutaminase Modulates Vascular Stiffness and Function Through Crosslinking-Dependent and Crosslinking-Independent Functions. J Am Heart Assoc (2017) 0.75

Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol (2010) 9.44

Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam Study. Circulation (2006) 8.18

Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part I: aging arteries: a "set up" for vascular disease. Circulation (2003) 7.40

Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation (1997) 7.34

Regular aerobic exercise prevents and restores age-related declines in endothelium-dependent vasodilation in healthy men. Circulation (2000) 4.32

Effects of age and aerobic capacity on arterial stiffness in healthy adults. Circulation (1993) 3.94

Arterial stiffness, wave reflections, and the risk of coronary artery disease. Circulation (2003) 3.67

Arterial aging: is it an immutable cardiovascular risk factor? Hypertension (2005) 3.55

Effect of exercise training on endothelium-derived nitric oxide function in humans. J Physiol (2004) 3.48

Effects of aging on changing arterial compliance and left ventricular load in a northern Chinese urban community. Circulation (1983) 3.09

Pulse wave velocity is an independent predictor of the longitudinal increase in systolic blood pressure and of incident hypertension in the Baltimore Longitudinal Study of Aging. J Am Coll Cardiol (2008) 2.75

Aortic diameter, aortic stiffness, and wave reflection increase with age and isolated systolic hypertension. Hypertension (2005) 2.36

Mechanisms of vascular aging: new perspectives. J Gerontol A Biol Sci Med Sci (2010) 2.24

Transglutaminases and disease: lessons from genetically engineered mouse models and inherited disorders. Physiol Rev (2009) 2.17

Clinical measurement of arterial stiffness obtained from noninvasive pressure waveforms. Am J Hypertens (2005) 2.09

Cardiovascular regulatory mechanisms in advanced age. Physiol Rev (1993) 2.02

Risk index for perioperative renal dysfunction/failure: critical dependence on pulse pressure hypertension. Circulation (2007) 2.01

Increased central artery stiffness in impaired glucose metabolism and type 2 diabetes: the Hoorn Study. Hypertension (2003) 2.00

Effects of aging on arterial distensibility in populations with high and low prevalence of hypertension: comparison between urban and rural communities in China. Circulation (1985) 1.98

Effect of aging on aortic morphology in populations with high and low prevalence of hypertension and atherosclerosis. Comparison between occidental and Chinese communities. Am J Pathol (1991) 1.76

Left ventricular pressure-volume relationship in a rat model of advanced aging-associated heart failure. Am J Physiol Heart Circ Physiol (2004) 1.67

Vasodilator-stimulated phosphoprotein serine 239 phosphorylation as a sensitive monitor of defective nitric oxide/cGMP signaling and endothelial dysfunction. Circ Res (2000) 1.60

Voluntary physical exercise-induced vascular effects in spontaneously hypertensive rats. Clin Sci (Lond) (2004) 1.54

Habitual exercise and vascular ageing. J Physiol (2009) 1.50

Pressure amplification explains why pulse pressure is unrelated to risk in young subjects. Hypertension (2001) 1.47

Cellular signaling and NO production. Pflugers Arch (2010) 1.38

Exercise training increases total systemic arterial compliance in humans. Am J Physiol (1994) 1.36

Extracellular TG2: emerging functions and regulation. FEBS J (2011) 1.35

Nitric oxide-mediated metabolic regulation during exercise: effects of training in health and cardiovascular disease. FASEB J (2000) 1.33

Moderate vs. high exercise intensity: differential effects on aerobic fitness, cardiomyocyte contractility, and endothelial function. Cardiovasc Res (2005) 1.30

Decreased S-nitrosylation of tissue transglutaminase contributes to age-related increases in vascular stiffness. Circ Res (2010) 1.30

Vascular stiffness and increased pulse pressure in the aging cardiovascular system. Cardiol Res Pract (2011) 1.28

Transglutaminase inhibition by 2-[(2-oxopropyl)thio]imidazolium derivatives: mechanism of factor XIIIa inactivation. Biochemistry (1994) 1.22

Running speed and maximal oxygen uptake in rats and mice: practical implications for exercise training. Eur J Cardiovasc Prev Rehabil (2007) 1.22

Vascular aging: from molecular mechanism to clinical significance. Geriatr Gerontol Int (2010) 1.19

Age-related changes in endothelial function and blood flow regulation. Pharmacol Ther (2011) 1.14

Exercise training enhances flow-induced vasodilation in skeletal muscle resistance arteries of aged rats: role of PGI2 and nitric oxide. Am J Physiol Heart Circ Physiol (2007) 1.11

A comprehensive histopathological evaluation of vascular medial fibrosis: insights into the pathophysiology of arterial stiffening. Atherosclerosis (2009) 1.09

Smoking and caffeine have a synergistic detrimental effect on aortic stiffness and wave reflections. J Am Coll Cardiol (2004) 1.03

Vascular nitric oxide: effects of exercise training in animals. Appl Physiol Nutr Metab (2008) 0.99

Increased tissue transglutaminase activity contributes to central vascular stiffness in eNOS knockout mice. Am J Physiol Heart Circ Physiol (2013) 0.98

Aortic stiffness is associated with vascular calcification and remodeling in a chronic kidney disease rat model. Am J Physiol Renal Physiol (2011) 0.96

The vasodilator-stimulated phosphoprotein is regulated by cyclic GMP-dependent protein kinase during neutrophil spreading. J Immunol (2001) 0.91

Exercise-induced modulation of endothelial nitric oxide production. Curr Pharm Biotechnol (2011) 0.88

Nitric oxide regulates tissue transglutaminase localization and function in the vasculature. Amino Acids (2011) 0.86

Nitric oxide regulates non-classical secretion of tissue transglutaminase. Commun Integr Biol (2011) 0.86

Simulated microgravity produces attenuated baroreflex-mediated pressor, chronotropic, and inotropic responses in mice. Am J Physiol Heart Circ Physiol (2005) 0.85

Progressive resistance training might improve vascular function in older women but not in older men. J Sci Med Sport (2012) 0.84

Definition of the fine specificity of the monoclonal antibody 81D4: its reactivity with lysine and polyamine isopeptide cross-links. J Immunol Methods (2004) 0.78

[Molecular genetics of cardiovascular diseases]. Rinsho Byori (1998) 0.77

Molecular definition of breast tumor heterogeneity. Cancer Cell (2007) 12.67

Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science (2006) 10.25

DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer. J Clin Oncol (2009) 6.43

Tracking the clonal origin of lethal prostate cancer. J Clin Invest (2013) 5.79

A new diagnostic test for arrhythmogenic right ventricular cardiomyopathy. N Engl J Med (2009) 4.54

Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms. Nature (2002) 3.92

Heterogeneity of breast cancer metastases: comparison of therapeutic target expression and promoter methylation between primary tumors and their multifocal metastases. Clin Cancer Res (2008) 3.67

Disruption of leptin signaling contributes to cardiac hypertrophy independently of body weight in mice. Circulation (2003) 3.30

Arginase reciprocally regulates nitric oxide synthase activity and contributes to endothelial dysfunction in aging blood vessels. Circulation (2003) 3.01

Cell type-specific DNA methylation patterns in the human breast. Proc Natl Acad Sci U S A (2008) 2.99

Hydrogen sulfide as endothelium-derived hyperpolarizing factor sulfhydrates potassium channels. Circ Res (2011) 2.94

Quantification of wave reflection in the human aorta from pressure alone: a proof of principle. Hypertension (2006) 2.82

Endothelial arginase II: a novel target for the treatment of atherosclerosis. Circ Res (2008) 2.70

Inducible NO synthase dependent S-nitrosylation and activation of arginase1 contribute to age-related endothelial dysfunction. Circ Res (2007) 2.62

Nitric oxide regulation of myocardial contractility and calcium cycling: independent impact of neuronal and endothelial nitric oxide synthases. Circ Res (2003) 2.44

Oxidized low-density lipoprotein-dependent endothelial arginase II activation contributes to impaired nitric oxide signaling. Circ Res (2006) 2.42

Knockdown of arginase I restores NO signaling in the vasculature of old rats. Hypertension (2005) 2.37

Norepinephrine up-regulates the expression of vascular endothelial growth factor, matrix metalloproteinase (MMP)-2, and MMP-9 in nasopharyngeal carcinoma tumor cells. Cancer Res (2006) 2.32

Decreased erythrocyte deformability after transfusion and the effects of erythrocyte storage duration. Anesth Analg (2013) 2.29

The relationship of age with regional aortic stiffness and diameter. JACC Cardiovasc Imaging (2010) 2.10

Cold-induced cutaneous vasoconstriction is mediated by Rho kinase in vivo in human skin. Am J Physiol Heart Circ Physiol (2006) 2.08

TGFβ receptor mutations impose a strong predisposition for human allergic disease. Sci Transl Med (2013) 2.08

Impaired red blood cell deformability after transfusion of stored allogeneic blood but not autologous salvaged blood in cardiac surgery patients. Anesth Analg (2014) 2.04

Neuronal nitric oxide synthase negatively regulates xanthine oxidoreductase inhibition of cardiac excitation-contraction coupling. Proc Natl Acad Sci U S A (2004) 1.91

BIN1 is reduced and Cav1.2 trafficking is impaired in human failing cardiomyocytes. Heart Rhythm (2011) 1.85

T1 Mapping in cardiomyopathy at cardiac MR: comparison with endomyocardial biopsy. Radiology (2012) 1.83

Reversal of cardiac hypertrophy and fibrosis from pressure overload by tetrahydrobiopterin: efficacy of recoupling nitric oxide synthase as a therapeutic strategy. Circulation (2008) 1.82

Apurinic/apyrimidinic endonuclease 1 regulates endothelial NO production and vascular tone. Circ Res (2004) 1.81

Hypertrophic cardiomyopathy: a review. Anesth Analg (2015) 1.78

Arginase inhibition restores NOS coupling and reverses endothelial dysfunction and vascular stiffness in old rats. J Appl Physiol (1985) (2009) 1.76

The role of tissue transglutaminase in cell-matrix interactions. Front Biosci (2006) 1.65

Arterial stiffening precedes systolic hypertension in diet-induced obesity. Hypertension (2013) 1.65

Determination of aortic pulse wave velocity from waveform decomposition of the central aortic pressure pulse. Hypertension (2008) 1.63

Cyclic AMP-Rap1A signaling activates RhoA to induce α(2c)-adrenoceptor translocation to the cell surface of microvascular smooth muscle cells. Am J Physiol Cell Physiol (2012) 1.62

A rasopathy phenotype with severe congenital hypertrophic obstructive cardiomyopathy associated with a PTPN11 mutation and a novel variant in SOS1. Am J Med Genet A (2012) 1.62

sRAGE and risk of diabetes, cardiovascular disease, and death. Diabetes (2013) 1.61

Impaired shear stress-induced nitric oxide production through decreased NOS phosphorylation contributes to age-related vascular stiffness. J Appl Physiol (1985) (2006) 1.59

Increased expression of cyclooxygenase-2 mediates enhanced contraction to endothelin ETA receptor stimulation in endothelial nitric oxide synthase knockout mice. Circ Res (2006) 1.58

A Pkd1-Fbn1 genetic interaction implicates TGF-β signaling in the pathogenesis of vascular complications in autosomal dominant polycystic kidney disease. J Am Soc Nephrol (2013) 1.49

Inhibition of NADPH oxidase activation in endothelial cells by ortho-methoxy-substituted catechols. Endothelium (2002) 1.46

Microgravity-induced changes in aortic stiffness and their role in orthostatic intolerance. J Appl Physiol (1985) (2006) 1.46

Flow-mediated dilatation as a biomarker for cardiovascular risk in hypertension. J Hypertens (2008) 1.44

Critical role for the alpha-1B adrenergic receptor at the sympathetic neuroeffector junction. Hypertension (2004) 1.44

A central role of plasmin in cardiac injury initiated by fetal exposure to maternal anti-Ro autoantibodies. Rheumatology (Oxford) (2013) 1.41

Weight loss, blood pressure reduction, and aortic stiffness: an old dilemma revisited. Obesity (Silver Spring) (2011) 1.37

Arginase modulates myocardial contractility by a nitric oxide synthase 1-dependent mechanism. Proc Natl Acad Sci U S A (2006) 1.36

Validity and repeatability of the Vicorder apparatus: a comparison with the SphygmoCor device. Hypertens Res (2009) 1.34

Histopathologic findings in ascending aortas from individuals with Loeys-Dietz syndrome (LDS). Am J Surg Pathol (2009) 1.34

Arginase and vascular aging. J Appl Physiol (1985) (2008) 1.33

The diagnosis of hypertrophic cardiomyopathy by cardiovascular magnetic resonance. J Cardiovasc Magn Reson (2012) 1.32

Cardiac myocyte apoptosis is associated with increased DNA damage and decreased survival in murine models of obesity. Circ Res (2005) 1.30

Decreased S-nitrosylation of tissue transglutaminase contributes to age-related increases in vascular stiffness. Circ Res (2010) 1.30

Transglutaminase regulation of cell function. Physiol Rev (2014) 1.28

Vascular stiffness and increased pulse pressure in the aging cardiovascular system. Cardiol Res Pract (2011) 1.28

Cellular functions of tissue transglutaminase. Int Rev Cell Mol Biol (2012) 1.27

Rho kinase-mediated local cold-induced cutaneous vasoconstriction is augmented in aged human skin. Am J Physiol Heart Circ Physiol (2007) 1.26

2011 consensus statement on endomyocardial biopsy from the Association for European Cardiovascular Pathology and the Society for Cardiovascular Pathology. Cardiovasc Pathol (2011) 1.24

Adverse ventricular remodeling and exacerbated NOS uncoupling from pressure-overload in mice lacking the beta3-adrenoreceptor. J Mol Cell Cardiol (2009) 1.24

Unconventional secretion of tissue transglutaminase involves phospholipid-dependent delivery into recycling endosomes. PLoS One (2011) 1.22

Cell surface transglutaminase promotes RhoA activation via integrin clustering and suppression of the Src-p190RhoGAP signaling pathway. Mol Biol Cell (2006) 1.21

Mitochondrial arginase II constrains endothelial NOS-3 activity. Am J Physiol Heart Circ Physiol (2007) 1.21

Tissue- and age-dependent expression of RNA-binding proteins that influence mRNA turnover and translation. Aging (Albany NY) (2009) 1.20

The impact of cyclooxygenase-2 mediated inflammation on scarless fetal wound healing. Am J Pathol (2004) 1.20

Rac1 leads to phosphorylation-dependent increase in stability of the p66shc adaptor protein: role in Rac1-induced oxidative stress. Mol Biol Cell (2005) 1.15

Upregulation of inducible nitric oxide synthase contributes to attenuated cutaneous vasodilation in essential hypertensive humans. Hypertension (2011) 1.15

Identification of a novel recognition sequence for fibronectin within the NH2-terminal beta-sandwich domain of tissue transglutaminase. J Biol Chem (2005) 1.14

Fatal outcome of a calcified amorphous tumor of the heart (cardiac CAT). Cardiovasc Pathol (2006) 1.14

Increased endothelial exocytosis and generation of endothelin-1 contributes to constriction of aged arteries. Circ Res (2010) 1.13

OxLDL-dependent activation of arginase II is dependent on the LOX-1 receptor and downstream RhoA signaling. Atherosclerosis (2010) 1.12

Enhanced proliferation of cultured human vascular smooth muscle cells linked to increased function of RNA-binding protein HuR. J Biol Chem (2005) 1.12

Regulation of alpha(2)-adrenoceptors in human vascular smooth muscle cells. Am J Physiol Heart Circ Physiol (2003) 1.11

Pulse pressure is an age-independent predictor of stroke development after cardiac surgery. Hypertension (2007) 1.11

Extranodal Rosai-Dorfman disease involving the heart: report of two cases. Cardiovasc Pathol (2009) 1.11